ArticleBMC cardiovascular disorders2025
Cardiac and pericardial hydatid cysts: a single center analysis of 22 cases.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Contamination-controlled cystectomy and ventricular wall reconstruction for an intramyocardial hydatid cyst of the left ventricle.JTCVS techniques · 2026Article
- Rapid formation of pseudoaneurysm of the mitral-aortic intervalvular fibrosa in a patient with bicuspid aortic valve and infective endocarditis: a case report.Journal of medical case reports · 2026Article
- Common and Rare Radiological Findings of Pulmonary and Thoracic Hydatid Cysts.The Eurasian journal of medicine · 2026Article
- Right-Ventricle-Adjacent Mass: A Multimodality Imaging Approach to Diagnosis.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesCardiac and pericardial hydatid cysts are rare, with cardiac involvement observed in only 0.02-2% of all cases in the body. In this study, we evaluated the clinical characteristics, anatomical distribution, and treatment strategies of cardiac and pericardial hydatid cyst cases treated in our clinic. Additionally, a comprehensive review of the literature was conducted.
methodsIn this single-center retrospective study, the outcomes of 22 consecutive cases with cardiac and pericardial hydatid cysts were analyzed between January 2008 and May 2023. Patients were followed for an average of 5.3 years from the time of diagnosis.
resultsOf the 22 cases, 10 were male (45.4%) and 12 were female (54.6%), with a mean age of 31.9 ± 20.3 years (range: 7-79 years). The most common presenting symptoms were chest pain (50.0%), dyspnea (22.7%), and cough (18.2%). Cardiac involvement was present in 18 patients (81.8%) and pericardial involvement in 4 patients (18.2%). Among the 18 patients with cardiac hydatid cysts, 8 had involvement of the left ventricle, 5 of the right ventricle, and 5 of the interventricular septum. Isolated cardiac involvement was observed in 8 patients (36.6%), while in 14 patients (63.4%) hydatid cysts were also present in other organs. Pulmonary involvement was found in 9 patients (40.9%), hepatic in 8 (36.4%), splenic in 2 (9.1%), diaphragmatic in 2 (9.1%), and single cases of cerebral, renal, chest wall, and psoas muscle involvement were also identified. Surgical treatment was performed in 20 patients (90.9%), while 2 patients (9.1%) received only medical therapy due to refusal of surgery. Among the surgically treated patients, 17 (85.0%) underwent median sternotomy, and 3 (15.0%) were treated via left anterior thoracotomy. No recurrence of cardiac or pericardial hydatid cysts was observed in any of the surgically treated cases. There was no surgery-related mortality. However, both patients who received only medical treatment died due to cyst-related complications during their one- and two-year follow-up respectively.
conclusionsCardiac involvement of hydatid cysts is a life-threatening condition that requires prompt surgical intervention. Postoperative albendazole therapy should be administered to prevent recurrence. In patients who refuse surgery, medical therapy may offer limited prolongation of survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.